| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $144.8M | +4.9% |
| Cost of Revenue | $37.4M | +7.1% |
| Gross Profit | $107.4M | +4.2% |
| R&D Expense | $51.5M | -0.2% |
| SG&A Expense | $41.0M | +23.5% |
| Operating Income | -$61.7M | -23.8% |
| Pre-tax Income | -$55.4M | -32.9% |
| Income Tax | $332K | -25.1% |
| Net Income | -$55.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $52.8M | -66.9% |
| Short-term Investments | $76.4M | — |
| Accounts Receivable | $23.1M | -14.4% |
| Current Assets | $156.9M | -18.4% |
| Total Assets | $180.3M | -22.1% |
| Current Liabilities | $25.7M | +11.1% |
| Total Liabilities | $32.8M | +5.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.7M | +65.7% |
| Capital Expenditures | $2.8M | -42.8% |
| Investing Cash Flow | -$78.0M | -289.5% |
| Financing Cash Flow | -$20.0M | -1167.6% |
| Free Cash Flow | -$11.5M | +62.1% |
| -32.3% |
| EPS (Basic) | -$0.93 | -32.9% |
| EPS (Diluted) | -$0.93 | -32.9% |
| Stockholders' Equity |
| $147.5M |
| -26.4% |